Patents by Inventor Maria Cornelia Wilhelmina Van Hulten

Maria Cornelia Wilhelmina Van Hulten has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Proteins derived from white spot syndrome virus and uses thereof
    Patent number: 8114977
    Abstract: Embodiments of the present invention generally relate to proteins derived from white spot syndrome virus, nucleic acid sequences encoding them, and their use in the manufacture of a vaccine for prophylaxis and/or treatment of white spot syndrome in crustaceans.
    Type: Grant
    Filed: June 18, 2010
    Date of Patent: February 14, 2012
    Assignee: Intervet International B.V.
    Inventors: Maria Cornelia Wilhelmina Van Hulten, Justinus Maria Vlak
  • Proteins derived from white spot syndrome virus and uses thereof
    Patent number: 7749506
    Abstract: Embodiments of the present invention generally relate to proteins derived from white spot syndrome virus, nucleic acid sequences encoding them, and their use in the manufacture of a vaccine for prophylaxis and/or treatment of white spot syndrome in crustaceans.
    Type: Grant
    Filed: April 19, 2007
    Date of Patent: July 6, 2010
    Assignee: Intervet International B.V.
    Inventors: Maria Cornelia Wilhelmina van Hulten, Justinus Maria Vlak
  • Antigenic proteins of shrimp white spot syndrome virus and uses thereof
    Patent number: 6908616
    Abstract: The present invention relates to antigenic proteins derived from White Spot Syndrome virus having an estimated size of 19 kDa (VP 19) or 13 kDA (VP13), to the use of these proteins in vaccines and to vaccines on the basis of these proteins. Furthermore, the invention relates to antibodies against these proteins and to the use of antibodies in vaccines, to nucleic acid sequences encoding these proteins and to their use in vaccines. Also, the invention relates to the use of said proteins in the manufacture of a vaccine for prophylaxis and/or treatment of White Spot Syndrome in crustaceans, to vector vaccines and to diagnostic kits comprising said nuclei acids or antibodies.
    Type: Grant
    Filed: September 14, 2001
    Date of Patent: June 21, 2005
    Assignee: Akzo Nobel N.V.
    Inventors: Justinus Maria Vlak, Maria Cornelia Wilhelmina Van Hulten
  • Antigenic proteins of shrimp white spot syndrome virus and uses thereof
    Publication number: 20040028700
    Abstract: The present invention relates to antigenic proteins derived from White Spot Syndrome virus having an estimated size of 19 kDa (VP 19) or 13 kDA (VP13), to the use of these proteins in vaccines and to vaccines on the basis of these proteins. Furthermore, the invention relates to antibodies against these proteins and to the use of antibodies in vaccines, to nucleic acid sequences encoding these proteins and to their use in vaccines. Also, the invention relates to the use of said proteins in the manufacture of a vaccine for prophylaxis and/or treatment of White Spot Syndrome in crustaceans, to vector vaccines and to diagnostic kits comprising said nuclei acids or antibodies.
    Type: Application
    Filed: September 16, 2002
    Publication date: February 12, 2004
    Inventors: Justinus Maria Vlak, Maria Cornelia Wilhelmina Van Hulten